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Prescient IgG4
IgG4 anti-desmoglein 1 (Dsg1)  
rises dramatically upon 
progression of endemic 
pemphigus foliaceus (fogo 
selvagem, FS). The etiological 
agents that trigger this 
autoimmune disease, which 
occurs mainly in impoverished 
regions of Brazil, are not known. 
Qaqish and colleagues developed 
a specific IgG4 anti-Dsg1 classifier 
assay with a sensitivity of 92% and 
a specificity of 97% that accurately 
predicts the development of 
FS in individuals. This assay will 
be used to identify individuals 
in the preclinical stages of FS 
for close surveillance to assess 
environmental factors that may 
play a role in triggering this 
disease. See page 110
Inside Melano cytic 
Nevi
Patients with large congenital 
melanocytic nevi (CMNs) have 
an increased risk for melanoma, 
although only 20–30% of 
melanomas arise from preexisting 
melanocytic nevi. Using samples 
from large CMNs, Dessars 
and colleagues performed an 
extensive genetic investigation 
involving karyotyping, mutational 
screening, and microarray 
analysis. NRAS mutations were 
found more frequently than 
BRAF mutations, which are 
common in small congenital and 
acquired nevi. Gene expression 
profiles revealed dysregulation 
in pigmentation, DNA damage 
repair, and chemoresistance 
pathways in CMNs. The biological 
significance of these interesting 
findings will be addressed in 
future studies into the mechanism 
of progression from CMN to 
melanoma.  See page 139
Diagnosis Improved
Noninvasive diagnosis of melanoma during 
the curable stages is the ultimate diagnostic 
goal. Guitera and colleagues evaluated in vivo 
reflectance confocal microscopy (RCM) for the 
management of melanocytic skin lesions. This 
method had been previously investigated only 
in small-scale studies. Compared with routine-
ly performed dermoscopy, RCM had superior 
specificity and equal sensitivity. Particular suc-
cess in diagnosing light-colored lesions was 
achieved with this method. These results sup-
port a role for RCM in secondary evaluation 
of lesions identified as suspicious by dermo-
scopy. See page 131
Metabolism of Psoriasis Treatment
Fumaric acid esters are a safe and effective treat-
ment for psoriasis. Dimethylfumarate (DMF), one 
component of the marketed Fumaderm, is the 
active compound in vitro; however, the active 
compound in vivo remains unclear because only 
the hydrolysis product of DMF, monomethylfu-
marate, was detected in plasma following oral 
intake. Liquid chromatography–mass spectro-
metric analysis revealed that N-acetyl-S-(1,2-
dimethyoxycarbonylethyl)cysteine was present 
in the urine of treated patients, indicating that DMF treatment is glutathione con-
sumptive. This result suggests that the mechanism of action of fumaric acid esters 
in psoriasis is based on DMF depletion of glutathione in immune cells, leading to 
apoptosis or the generation of anti-inflammatory cytokines. See page 231
Virus Frequent Flyer in Merkel Cell Carcinoma
The aggressive malignancy merkel cell 
carcinoma (MCC) is related to immuno-
suppression. A novel polyomavirus 
(MCPyV) integrated in MCC tumors was 
recently identified, implying a causative 
role for this virus. In two recent reports, 
the association between MCPyV and 
MCC was confirmed in multiple tumor 
samples. In these studies, 84.9 and 43% 
of the samples were determined to be 
virus positive. Interestingly, the propor-
tion of tumors positive for MCPyV was 
greater in samples from North America 
than in samples from Australia. In addition to opening new lines of study into the 
molecular mechanisms of MCC initiation and progression, these results support 
the exploration of antivirals and immunotherapy for treatment of MCC. See pages 
248 and 250
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